#CNXIT History of IT Sector in India: A data-based perspective
In last 1.5 years, we witnessed a heavy price correction in IT sector. This is evident from CNXIT index movement which is 32% down in last 1.5 years (we kept cautioning repeatedly then)
Now, sector is also facing headwinds. Typically, this is how market behaves. Market is always ahead of reality. It tops when valuations highlight major froth, smart money slowly exits n new entrants think they know it all, are scapegoats. Companies r lowering their guidance.
Within a year, we have come from healthy double digit growth to low to mid single digit growth projection. Question is - Is it something new or there is something to learn from history?
History is an interesting subject and price is the first guide. Lets us look at history
When we look at IT index history, we realize that current correlation is not 1st one. The last major correction happened in 2014-16 when CNXIT was 25% down for 2 years. This was the time when current 50x stocks were available at 15x and still there was lot of pessimism.
Do you know why CNXIT went through such correction? Let me give you some hints. Below is the table which provides global IT spending data for last 19 years. Look what happened to global IT spending during 2014-16 period on 1- and 3-year CAGR. It went through its worst -2 to -5%
Also, what is noteworthy about it is that 2021 was a year of record high global IT spending. The last such spending happened just before 2008 recession. Now, again, we are talking about recession. Call it co-incidence or whatever but data always throws important stuff.
Let me throw one more interesting data stuff. I tried to find correlation between global IT spending YoY growth rate and few more indicators and found 91% strong correlation between global IT spending YoY growth and this indicator.
This is just one of the interesting insights among many we are covering in our IT sector super session where we already had 1 session and there are 2-3 more sessions planned to cover this sector in utmost detail. Want to know more, join us here: learn.scientificinvesting.in/learn/IT
1/15 🚀 Introducing Aarti Pharmalabs Ltd!
They make APIs, Xanthine Derivatives, and offer CDMO/CMO services for drug development and manufacturing.
Let’s break it down step by step! 🧵👇
2/15 🏢 Company Background:
● Originally part of Aarti Industries, Aarti Pharmalabs became a separate entity in 2022.
● Focus: Manufacturing key pharmaceutical ingredients, intermediates, and offering contract manufacturing for drug development.
● Their goal? To supply high-quality ingredients for medicines, energy drinks, and supplements globally.
3/15 🌿 What are APIs (Active Pharmaceutical Ingredients)?
● APIs are the active components in medicines that provide therapeutic effects.
○ Example: The ingredient in cancer, pain relief, and respiratory drugs.
● Intermediates are chemical compounds used to create APIs.
○ Think of intermediates as the building blocks of medicines
➡️ Aarti manufactures both!
RBI released Financial Stability Report - Dec 2024 (half yearly publication covering financial sector)
🧵 sharing key insights and visuals from the report covering macro, banking, investment and other regulatory aspects after going through the report
To start with market, how much the EPS needs to grow to justify the existing valuation against historic multiple.
Against this, Q2 growth was below 10% YoY
Do track our newsletters where we cover such things in detail on quarterly basis:
Subscribe to Newsletters: scientificinvesting.in
For Chemicals Sector, based on Q2FY25 result:
❓Best performing chemical companies?
❓Attractively valued chemical companies?
❓Both attractively valued and best performing?
🧵to answer all such questions to help to filter interesting ideas for research
For Plastics Products and Packaging Sector, Q2FY25 result:
❓Best performing companies?
❓Attractively valued companies?
❓Both attractively valued and best performing?
🧵to answer all such questions to help to filter interesting ideas for research